Evidence map›Paper›PMID 37999003›Full record

ArticleGels (Basel, Switzerland)2023

Injectable Decellularized Extracellular Matrix-Based Bio-Ink with Excellent Biocompatibility for Scarless Urethra Repair.

Wenzhuo Fang, Ming Yang, Yangwang Jin, Kaile Zhang, Ying Wang, Meng Liu, Yuhui Wang, Ranxing Yang, Qiang Fu

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Supercritical COACS omega · 2024
    Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wenzhuo FangDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.
Ming YangDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.
Yangwang JinDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.
Kaile ZhangDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.
Ying WangDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.
Meng LiuDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.
Yuhui WangDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.
Ranxing YangDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.
Qiang FuDepartment of Urology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, No. 600 Yi-Shan Road, Shanghai 200233, China.

Funding

the Interdisciplinary Program of Shanghai Jiao Tong University No. YG2022ZD020the National Natural Scientific Foundation of China No. 82170694, 82370684the Natural Science Foundation of Shanghai No. 20ZR1442100
6 · The paper itself

Abstract

In recent years, decellularized extracellular matrices (dECM) derived from organs have attracted much attention from researchers due to their excellent biocompatibility, capacity to promote cell proliferation and migration, as well as pro-vascularization. However, their inferior mechanical properties, slow cross-linking, weak strengths, and poor supporting properties remain their inevitable challenges. In our study, we fabricated a novel dECM hydrogel with better crosslinking strength and speed, stronger support properties, and better mechanical properties. The hydrogel, which we named gelatin-based dECM powder hydrogel (gelatin-dECM hydrogel), was prepared by mixing dECM microparticles in gelatin solution and adding certain amount of 1-Ethyl-3-(3-dimethyl-aminopropyl-1-carbodiimide) (EDC) and N-hydroxysuccinimide (NHS). We evaluated the utility of this hydrogel by assessing the degradation rate, mechanical properties, and biocompatibility. The results showed that the gelatin-dECM hydrogel has high mechanical properties and biocompatibility and also has the ability to promote cell proliferation and migration. After injection of this hydrogel around the surgical sites of urethras in rabbits, the incorporation of dECM powder was demonstrated to promote angiogenesis as well as scarless repair by histological sections after surgery. The application of this novel hydrogel provides a new perspective for the treatment of post-traumatic urethral stricture.

Indexed as

dECMgelatinhydrogelscarless repairtissue engineering

Identifiers

PMID37999003
PMCPMC10670918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.